UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 1.351

Sortiert nach

The role of the brain renin-angiotensin system in hypertension: implications for new treatment

Progress in neurobiology, 2011-10, Vol.95 (2), p.89-103

2011

Volltextzugriff (PDF)

Effects of firibastat in combination with enalapril and hydrochlorothiazide on blood pressure and vasopressin release in hypertensive DOCA-salt rats

Biomedicine & pharmacotherapy, 2021-08, Vol.140, p.111682-111682, Article 111682

2021

Volltextzugriff (PDF)

From the Soft to the Hard: Changes in Microchemistry During Cell Wall Maturation of Walnut Shells

Frontiers in plant science, 2020-04, Vol.11, p.466-466

2020

Volltextzugriff (PDF)

Central antihypertensive effects of chronic treatment with RB150: an orally active aminopeptidase A inhibitor in deoxycorticosterone acetate-salt rats

Journal of hypertension, 2018-03, Vol.36 (3), p.641-650

2018

Volltextzugriff (PDF)

Brain ACE2 activation following brain aminopeptidase A blockade by firibastat in salt-dependent hypertension

Clinical science (1979), 2021-03, Vol.135 (6), p.775

2021

Volltextzugriff (PDF)

Targeting Brain Aminopeptidase A: A New Strategy for the Treatment of Hypertension and Heart Failure

Canadian journal of cardiology, 2020-05, Vol.36 (5), p.721-731

2020

Volltextzugriff (PDF)

A new strategy for treating hypertension by blocking the activity of the brain renin-angiotensin system with aminopeptidase A inhibitors

Clinical science (1979), 2014-08, Vol.127 (3), p.135

2014

Volltextzugriff (PDF)

Brain renin-angiotensin system blockade with orally active aminopeptidase A inhibitor prevents cardiac dysfunction after myocardial infarction in mice

Journal of molecular and cellular cardiology, 2019-02, Vol.127, p.215-222

2019

Volltextzugriff (PDF)

MPS 18-01 MODE OF ACTION OF RB150, AN AMINOPEPTIDASE A INHIBITOR PRODRUG AS A CENTRALLY-ACTING ANTIHYPERTENSIVE AGENT IN DOCA-SALT HYPERTENSIVE RATS

Journal of hypertension, 2016-09, Vol.34 (Supplement 1), p.e423

2016

Volltextzugriff (PDF)

Brain renin-angiotensin system blockade with orally active aminopeptidase A inhibitor prevents cardiac dysfunction after myocardial infarction in mice

Journal of molecular and cellular cardiology, 2019-02, Vol.127, p.215-222

2019

Volltextzugriff (PDF)

Brain renin-angiotensin system blockade with orally active aminopeptidase A inhibitor prevents cardiac dysfunction after myocardial infarction in mice

Journal of molecular and cellular cardiology, 2019-02, Vol.127, p.215-222

2019

Volltextzugriff (PDF)

Specific Inhibition of Brain Angiotensin III Formation as a New Strategy for Prevention of Heart Failure After Myocardial Infarction

Journal of cardiovascular pharmacology, 2019-02, Vol.73 (2), p.82

2019

Volltextzugriff (PDF)

Central Antihypertensive Effects of Orally Active Aminopeptidase A Inhibitors in Spontaneously Hypertensive Rats

Hypertension (Dallas, Tex. 1979), 2012-08, Vol.60 (2), p.411-418

2012

Volltextzugriff (PDF)

QGC606: A Best-in-Class Orally Active Centrally Acting Aminopeptidase A Inhibitor Prodrug for Treating Heart Failure Following Myocardial Infarction

Canadian journal of cardiology, 2022-06, Vol.38 (6), p.815-827

2022

Volltextzugriff (PDF)

Orally Active Aminopeptidase A Inhibitors Reduce Blood Pressure: A New Strategy for Treating Hypertension

Hypertension (Dallas, Tex. 1979), 2008-05, Vol.51 (5), p.1318-1325

2008

Volltextzugriff (PDF)

Inhibition of brain angiotensin III attenuates sympathetic hyperactivity and cardiac dysfunction in rats post-myocardial infarction

Cardiovascular research, 2013-03, Vol.97 (3), p.424-431

2013

Volltextzugriff (PDF)

Aminopeptidase A inhibitors as centrally acting antihypertensive agents

Heart failure reviews, 2008-09, Vol.13 (3), p.311-319

2008

Volltextzugriff (PDF)

Differences in meristem size and expression of branching genes are associated with variation in panicle phenotype in wild and domesticated African rice

EvoDevo, 2017-01, Vol.8 (1), p.2-2, Article 2

2017

Volltextzugriff (PDF)

Orally Active Aminopeptidase A Inhibitors Reduce Blood Pressure : A New Strategy for Treating Hypertension. Commentary

Hypertension (Dallas, Tex. 1979), 2008, Vol.51 (5)

2008

Volltextzugriff (PDF)

A homogeneous measurement of the delay between the onsets of gas stripping and star formation quenching in satellite galaxies of groups and clusters

Monthly notices of the Royal Astronomical Society, 2021-03, Vol.501 (4), p.5073-5095

2021

Volltextzugriff (PDF)

Humoral Responses and Serological Assays in SARS-CoV-2 Infections

Frontiers in immunology, 2020-12, Vol.11, p.610688-610688

2020

Volltextzugriff (PDF)

Longitudinal follow-up of IgG anti-nucleocapsid antibodies in SARS-CoV-2 infected patients up to eight months after infection

Journal of clinical virology, 2021-03, Vol.136, p.104765-104765, Article 104765

2021

Volltextzugriff (PDF)

Polarization-Resolved Second-Harmonic Generation in Tendon upon Mechanical Stretching

Biophysical journal, 2012-05, Vol.102 (9), p.2220-2229

2012

Volltextzugriff (PDF)

Active integration of electric vehicles into distribution grids: Barriers and frameworks for flexibility services

Renewable & sustainable energy reviews, 2021-07, Vol.145, p.111060, Article 111060

2021

Volltextzugriff (PDF)

IL-6, RANKL, TNF-alpha/IL-1: interrelations in bone resorption pathophysiology

Cytokine & growth factor reviews, 2004-02, Vol.15 (1), p.49-60

2004

Volltextzugriff (PDF)

1 – 25 von 1.351

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.152)
Mit Volltextzugriff
(1.250)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(1.210)
Japanisch
(157)
Französisch
(143)
Deutsch
(6)
Italienisch
(2)
Spanisch
(1)
Welsh
(1)

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

EZB Electronic Journals Library
(612)
Ingenta
(534)
MEDLINE
(465)
Ovid Journals
(334)
Access via ScienceDirect (Elsevier)
(249)
IngentaConnect Journals
(229)
Access via Wiley Online Library
(204)
Single Journals
(199)
Wiley Online Library
(146)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(144)
SpringerNature Journals
(109)
IEEE Xplore
(71)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(61)
Oxford journals
(48)
Oxford Journals 2020 Medicine
(45)
Springer Nature - Connect here FIRST to enable access
(37)
JSTOR
(32)
Nexis Uni
(25)
Ebook Central Perpetual and DDA
(23)
Taylor & Francis
(23)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Plos One
(22)
Neuro-Oncology
(15)
Journal Of Neuro-Oncology
(14)
The Journal Of Biological Chemistry
(12)
Angewandte Chemie
(10)
Annals Of Intensive Care
(9)
Annuaire De L'ehess
(9)
Cancer Research
(9)
Cheminform
(9)
Chemistry : A European Journal
(9)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(13)

Menü

Weitere Dienste

Einstellungen

The role of the brain renin-angiotensin system in hypertension: implications for new treatment

Effects of firibastat in combination with enalapril and hydrochlorothiazide on blood pressure and vasopressin release in hypertensive DOCA-salt rats

From the Soft to the Hard: Changes in Microchemistry During Cell Wall Maturation of Walnut Shells

Central antihypertensive effects of chronic treatment with RB150: an orally active aminopeptidase A inhibitor in deoxycorticosterone acetate-salt rats

Brain ACE2 activation following brain aminopeptidase A blockade by firibastat in salt-dependent hypertension

Targeting Brain Aminopeptidase A: A New Strategy for the Treatment of Hypertension and Heart Failure

A new strategy for treating hypertension by blocking the activity of the brain renin-angiotensin system with aminopeptidase A inhibitors

Brain renin-angiotensin system blockade with orally active aminopeptidase A inhibitor prevents cardiac dysfunction after myocardial infarction in mice

MPS 18-01 MODE OF ACTION OF RB150, AN AMINOPEPTIDASE A INHIBITOR PRODRUG AS A CENTRALLY-ACTING ANTIHYPERTENSIVE AGENT IN DOCA-SALT HYPERTENSIVE RATS

Brain renin-angiotensin system blockade with orally active aminopeptidase A inhibitor prevents cardiac dysfunction after myocardial infarction in mice

Brain renin-angiotensin system blockade with orally active aminopeptidase A inhibitor prevents cardiac dysfunction after myocardial infarction in mice

Specific Inhibition of Brain Angiotensin III Formation as a New Strategy for Prevention of Heart Failure After Myocardial Infarction

Central Antihypertensive Effects of Orally Active Aminopeptidase A Inhibitors in Spontaneously Hypertensive Rats

QGC606: A Best-in-Class Orally Active Centrally Acting Aminopeptidase A Inhibitor Prodrug for Treating Heart Failure Following Myocardial Infarction

Orally Active Aminopeptidase A Inhibitors Reduce Blood Pressure: A New Strategy for Treating Hypertension

Inhibition of brain angiotensin III attenuates sympathetic hyperactivity and cardiac dysfunction in rats post-myocardial infarction

Aminopeptidase A inhibitors as centrally acting antihypertensive agents

Differences in meristem size and expression of branching genes are associated with variation in panicle phenotype in wild and domesticated African rice

Orally Active Aminopeptidase A Inhibitors Reduce Blood Pressure : A New Strategy for Treating Hypertension. Commentary

A homogeneous measurement of the delay between the onsets of gas stripping and star formation quenching in satellite galaxies of groups and clusters

Humoral Responses and Serological Assays in SARS-CoV-2 Infections

Longitudinal follow-up of IgG anti-nucleocapsid antibodies in SARS-CoV-2 infected patients up to eight months after infection

Polarization-Resolved Second-Harmonic Generation in Tendon upon Mechanical Stretching

Active integration of electric vehicles into distribution grids: Barriers and frameworks for flexibility services

IL-6, RANKL, TNF-alpha/IL-1: interrelations in bone resorption pathophysiology

Suchergebnisse filtern